Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion
- PMID: 7308281
- DOI: 10.1007/BF00618779
Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion
Abstract
The pharmacokinetics of short acting sulphonamides and a series of N4-acetylsulphonamide derivatives has been investigated. Sulphonamides with a sulphur atom two atomic bond distances from the N1 atom are excreted by active tubular secretion, e.g. sulphamethizole, sulphaethidole and sulphathiasole. When the sulphur atom is replaced by an oxygen or nitrogen atom, active renal excretion no longer occurs. N4-acetylsulphonamides are excreted by active tubular secretion. The renal clearance values of the N4-acetylsulphonamides are not influenced by the substituent at the N1 position. Two groups of N4-acetylsulphonamides can be distinguished. One has a T1/2 of 4-6 h and a renal clearance value of 20-60 ml/min and the second has a T1/2 of 10-20 h and a renal clearance of less than 10 ml/min. N4-acetylsulphonamides are deacetylated to the extent of about 5%.
Similar articles
-
Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.Pharm Weekbl Sci. 1984 Aug 24;6(4):150-6. doi: 10.1007/BF01954042. Pharm Weekbl Sci. 1984. PMID: 6483571
-
Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006. Clin Pharmacokinet. 1980. PMID: 7389236
-
Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.Clin Pharmacokinet. 1979 Jul-Aug;4(4):310-9. doi: 10.2165/00003088-197904040-00004. Clin Pharmacokinet. 1979. PMID: 487686
-
Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives.Antibiot Chemother (1971). 1982;31:22-118. doi: 10.1159/000400131. Antibiot Chemother (1971). 1982. PMID: 7036849 Review. No abstract available.
-
Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions.Am J Med. 1993 Mar 22;94(3A):56S-69S. Am J Med. 1993. PMID: 8383921 Review.
Cited by
-
The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.Pharm Weekbl Sci. 1983 Apr 29;5(2):49-56. doi: 10.1007/BF01960075. Pharm Weekbl Sci. 1983. PMID: 6866714
-
Pharmacokinetic considerations in rational drug design.Clin Pharmacokinet. 1994 Mar;26(3):161-8. doi: 10.2165/00003088-199426030-00001. Clin Pharmacokinet. 1994. PMID: 8194280 Review. No abstract available.
-
Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.Pharm Weekbl Sci. 1984 Aug 24;6(4):150-6. doi: 10.1007/BF01954042. Pharm Weekbl Sci. 1984. PMID: 6483571
-
Effect of intra-articular glucocorticoids on the disposition of sulphadimidine in chronic osteoarthritis patients.Br J Clin Pharmacol. 1988 Nov;26(5):563-8. doi: 10.1111/j.1365-2125.1988.tb05296.x. Br J Clin Pharmacol. 1988. PMID: 3207561 Free PMC article.
-
Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs.Pharm Weekbl Sci. 1984 Apr 27;6(2):80-7. doi: 10.1007/BF01953959. Pharm Weekbl Sci. 1984. PMID: 6547228
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources